These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 26175302)
1. Intravesical treatment with cis-urocanic acid improves bladder function in rat model of acute bladder inflammation. Konkol Y; Bernoulli J; Streng T; Jääskeläinen K; Laihia J; Leino L Neurourol Urodyn; 2016 Sep; 35(7):786-91. PubMed ID: 26175302 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 levels in female rats with protamine sulfate-induced chronic cystitis treated with hyaluronic acid. Lv YS; Yao YS; Lin ME; Rong L; Deng BH; Huang J; Hao WP Int J Urol; 2013 Oct; 20(10):1017-22. PubMed ID: 23379983 [TBL] [Abstract][Full Text] [Related]
3. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model. Sahiner IF; Soylu H; Ates E; Acar N; Ustunel I; Danisman A Int Braz J Urol; 2018; 44(5):1014-1022. PubMed ID: 30044599 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder. Arentsen HC; Jansen CF; Hulsbergen-van de Kaa CA; Laihia JK; Pylkkänen L; Leino L; Oosterwijk E; Witjes JA J Urol; 2012 Apr; 187(4):1445-9. PubMed ID: 22341270 [TBL] [Abstract][Full Text] [Related]
5. A rat long-lasting cystitis model induced by intravesical injection of hydrogen peroxide. Dogishi K; Okamoto K; Majima T; Konishi-Shiotsu S; Homan T; Kodera M; Oyama S; Oyama T; Shirakawa H; Yoshimura N; Nakagawa T; Kaneko S Physiol Rep; 2017 Feb; 5(4):. PubMed ID: 28242819 [TBL] [Abstract][Full Text] [Related]
6. Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats. Yıldız N; Alpay H; Tuğtepe H; Özdemir Kumral ZN; Akakın D; İlki A; Şener G; Ç Yeğen B Int J Urol; 2015 Jun; 22(6):598-603. PubMed ID: 25808602 [TBL] [Abstract][Full Text] [Related]
7. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis. Lv YS; Yao YS; Rong L; Lin ME; Deng BH; Xie Y; Huang H; Lin TX; Xu KW; Huang J Int J Urol; 2014 Jun; 21(6):601-7. PubMed ID: 24286489 [TBL] [Abstract][Full Text] [Related]
8. JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding function. Kitagawa Y; Wada M; Kanehisa T; Miyai A; Usui K; Maekawa M; Sakata M; Matsuo A; Hayashi M; Matsushita M J Urol; 2013 Mar; 189(3):1137-46. PubMed ID: 22999996 [TBL] [Abstract][Full Text] [Related]
9. Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis. Shao Y; Lu GL; Shen ZJ; He HC World J Urol; 2013 Jun; 31(3):535-40. PubMed ID: 22358112 [TBL] [Abstract][Full Text] [Related]
10. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide. Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032 [TBL] [Abstract][Full Text] [Related]
11. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886 [TBL] [Abstract][Full Text] [Related]
12. Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat. Fraser MO; Chuang YC; Tyagi P; Yokoyama T; Yoshimura N; Huang L; De Groat WC; Chancellor MB Urology; 2003 Mar; 61(3):656-63. PubMed ID: 12639679 [TBL] [Abstract][Full Text] [Related]
13. Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model. Lee YL; Lin KL; Chuang SM; Lee YC; Lu MC; Wu BN; Wu WJ; Yuan SF; Ho WT; Juan YS Am J Pathol; 2017 Sep; 187(9):1945-1959. PubMed ID: 28826558 [TBL] [Abstract][Full Text] [Related]
14. Intravesical administration of blebbistatin prevents cyclophosphamide-induced toxicity of the urinary bladder in female Wistar rats. Wróbel A; Serefko A; Bańczerowska-Górska M; Szopa A; Dudka J; Poleszak E Neurourol Urodyn; 2019 Apr; 38(4):1044-1052. PubMed ID: 30869827 [TBL] [Abstract][Full Text] [Related]
15. Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. Chuang YC; Chancellor MB; Seki S; Yoshimura N; Tyagi P; Huang L; Lavelle JP; De Groat WC; Fraser MO Urology; 2003 Mar; 61(3):664-70. PubMed ID: 12639680 [TBL] [Abstract][Full Text] [Related]
16. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis. Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172 [TBL] [Abstract][Full Text] [Related]
17. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. Beckel JM; Daugherty SL; Tyagi P; Wolf-Johnston AS; Birder LA; Mitchell CH; de Groat WC J Physiol; 2015 Apr; 593(8):1857-71. PubMed ID: 25630792 [TBL] [Abstract][Full Text] [Related]
18. A new method for producing urinary bladder hyperactivity using a non-invasive transient intravesical infusion of acetic acid in conscious rats. Mitobe M; Inoue H; Westfall TD; Higashiyama H; Mizuyachi K; Kushida H; Kinoshita M J Pharmacol Toxicol Methods; 2008; 57(3):188-93. PubMed ID: 18367412 [TBL] [Abstract][Full Text] [Related]
19. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder. Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976 [TBL] [Abstract][Full Text] [Related]